secwatch.observer — SEC 8-K summary
======================================

Issuer:     AiXin Life International, Inc. (AIXN)
CIK:        0000835662
Form:       8-K/A
Filed at:   2021-08-17T23:59:59+00:00
Accession:  0001493152-21-020400
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aixin Life files financial statements for acquired pharmacies; shows 2020 net loss of $185K
--------------------------------------------------------------------------------

- Acquired entity Chengdu Aixintang Pharmacy (9 pharmacies) had 2020 revenue of $1.26M and net loss of $185K.
- Accumulated deficit at Dec 2020 was $1.19M; stockholders' deficit of $987K.
- Pro forma financials also include hotel entity from a separate May 2021 acquisition.
- Amendment corrects prior 8-K which misstated the acquired entity's name.
- Audited and unaudited combined financials now filed for years ended 2020/2019 and Q1 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/0001493152-21-020400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/form-8ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-020400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer